ISO 35001:2019 - Biorisk Management for Laboratories Internal Auditor Free Practice Test — 30 Questions

Question 1

During an internal audit of a high-containment virology laboratory operating under ISO 35001:2019, an auditor is reviewing the initial phases of the biorisk management system (BRMS) development. The laboratory director has provided documentation outlining the identified biological agents, the risk assessment methodology, and the preliminary control measures. However, the auditor notices a significant omission: the documented process for systematically identifying and incorporating the specific requirements and concerns of various stakeholders, including national biosafety regulatory agencies, institutional biosafety committees, and the laboratory\'s own frontline technicians regarding their working conditions and safety perceptions. What critical element, as mandated by the standard, appears to be underdeveloped in the laboratory\'s approach to establishing its BRMS?

Accepted Answer

The systematic identification and consideration of interested parties and their relevant requirements.

Question 2

During an internal audit of a high-containment virology laboratory operating under ISO 35001:2019, an auditor observes that while comprehensive Standard Operating Procedures (SOPs) for the decontamination of equipment used with a novel influenza strain (classified as Risk Group 3) are documented and readily accessible, laboratory technicians exhibit varying degrees of diligence in completing the full multi-stage chemical inactivation process before initiating equipment cleaning. Specifically, one technician was observed bypassing the secondary rinse cycle during a routine equipment transfer simulation. What is the most accurate assessment of this situation from an internal audit perspective concerning the laboratory\'s biorisk management system?

Accepted Answer

The documented procedures for equipment decontamination are not being effectively implemented, indicating a potential breakdown in operational control.

Question 3

During an internal audit of a high-containment research laboratory, an auditor is reviewing the implementation of ISO 35001:2019. The auditor needs to verify that the laboratory has adequately addressed the requirements of understanding its context, particularly concerning external and internal issues that influence its biorisk management system. Which of the following audit activities would most effectively demonstrate the laboratory\'s compliance with the relevant clauses of the standard?

Accepted Answer

Reviewing documented evidence of a systematic process for identifying, analyzing, and documenting both internal and external factors impacting biorisk management, including relevant legal and regulatory requirements.

Question 4

During an internal audit of a high-containment laboratory specializing in the research of highly pathogenic avian influenza (HPAI) strains, an auditor reviews the biorisk management system documentation. The laboratory operates under national legislation that mandates stringent protocols for the handling, storage, and transport of such biological agents. The auditor observes that while the laboratory has a general biosafety policy, there is no explicit documented procedure detailing how the organization identifies, assesses, and integrates specific national legislative requirements pertaining to HPAI into its operational biorisk management framework. What is the most significant implication of this finding concerning the laboratory\'s adherence to ISO 35001:2019?

Accepted Answer

A failure to adequately address external issues relevant to the organization's context, potentially compromising the system's effectiveness and compliance.

Question 5

During an internal audit of a biosafety level 2 (BSL-2) laboratory, an auditor is reviewing the implementation of operational planning and control processes as stipulated by ISO 35001:2019. The laboratory handles several bacterial strains known to cause zoonotic infections. The auditor observes that while documented Standard Operating Procedures (SOPs) exist for specimen handling, decontamination, and waste disposal, there are inconsistencies in how staff members adhere to the specified decontamination cycles for reusable equipment and the segregation of biohazardous waste streams. Which of the following audit findings would most accurately reflect a deficiency in the laboratory\'s operational planning and control concerning biorisk management?

Accepted Answer

Inconsistent adherence to documented decontamination cycles and biohazardous waste segregation protocols by laboratory personnel.

Question 6

An internal auditor is reviewing the biorisk management system of a high-containment laboratory that conducts research on novel zoonotic pathogens. The laboratory\'s scope includes the manipulation of infectious agents requiring Biosafety Level 3 containment. During the audit, the auditor discovers that while the laboratory has a general awareness of biosafety principles, it has not systematically documented or integrated specific national and international regulatory requirements pertaining to the handling of such pathogens into its formal risk assessments and operational procedures. Which of the following findings would represent the most significant non-conformity with ISO 35001:2019, clause 4.1, \"Understanding the organization and its context\"?

Accepted Answer

Failure to explicitly identify and document all relevant national and international legal and regulatory requirements applicable to the specific biological agents and activities within the laboratory's scope.

Question 7

During an internal audit of a high-containment research laboratory, an auditor is reviewing the implementation of ISO 35001:2019. The laboratory handles several novel viral agents with potential for zoonotic transmission. The auditor needs to assess how effectively the laboratory has integrated external legal and regulatory requirements into its biorisk management system, as stipulated by the standard\'s foundational clauses. Which of the following audit activities would best demonstrate the auditor\'s verification of this integration?

Accepted Answer

Reviewing the documented procedure for identifying, assessing, and incorporating applicable national and international biosafety and biosecurity legislation and guidelines into the laboratory's operational protocols and risk assessments.

Question 8

During an internal audit of a biosafety level 3 laboratory, an auditor is reviewing the foundational elements of their biorisk management system. The laboratory director states that their primary commitment to managing biological agents is documented in a high-level statement that guides all subsequent risk assessments and control measures. What specific component of the biorisk management system, as defined by ISO 35001:2019, is the director most likely referring to as the cornerstone of their commitment?

Accepted Answer

The documented biorisk policy

Question 9

During an internal audit of a research laboratory handling novel viral agents, an auditor observes a technician disposing of contaminated pipette tips into a general waste bin rather than a designated biohazard sharps container. This observation indicates a potential breach in established biosafety procedures and a failure to implement documented risk control measures. Considering the principles of ISO 35001:2019, what is the most appropriate immediate action for the internal auditor to take in this situation?

Accepted Answer

Document the observed non-conformity and report it to the laboratory manager and the biorisk management representative for corrective action.

Question 10

During an internal audit of a high-containment biosafety laboratory operating under ISO 35001:2019, an auditor is reviewing the implementation of the biorisk management system. The laboratory has established various procedures for handling pathogenic agents, but the auditor observes a lack of clarity regarding who is ultimately accountable for the day-to-day oversight of specific biosafety protocols in different research units. While the Biosafety Officer (BSO) provides guidance, the direct supervision and enforcement of these protocols within each unit appear diffused. What is the most critical aspect for the auditor to verify to ensure effective implementation of the standard in this scenario?

Accepted Answer

The clear definition, communication, and understanding of biorisk management roles and responsibilities at all levels, including unit-specific accountability.

Question 11

An internal auditor is reviewing the biorisk management system of a high-containment laboratory specializing in research on novel zoonotic viruses. The laboratory operates under strict national biosafety legislation that mandates specific reporting timelines for any accidental release of biological agents and requires adherence to a tiered system of physical and biological containment based on the assessed risk of the agent. During the audit, the auditor discovers that while the laboratory has a general incident reporting procedure and a documented containment strategy, there is no explicit linkage within the biorisk management system\'s documented information that demonstrates how these specific legislative requirements for zoonotic virus research are integrated into the daily operational controls and emergency preparedness plans. What is the most significant implication of this finding for the laboratory\'s biorisk management system?

Accepted Answer

The biorisk management system may not adequately address critical external regulatory requirements for handling specific biological agents, potentially leading to non-compliance.

Question 12

A research laboratory specializing in virology has recently implemented a new automated liquid handling system for processing samples containing highly pathogenic avian influenza strains. This upgrade significantly alters the workflow and introduces new potential points of failure. As an internal auditor for the biorisk management system, what is the most critical immediate action to ensure compliance with ISO 35001:2019 principles following this operational change?

Accepted Answer

Initiate a full review and update of the biorisk assessment for all processes involving the new system, including the potential for aerosol generation and containment breaches, and revise the risk register accordingly.

Question 13

During an internal audit of a high-containment biosafety laboratory, an auditor is reviewing the initial establishment phase of their biorisk management system (BRMS) in accordance with ISO 35001:2019. The laboratory handles novel viral vectors and is subject to national biosecurity regulations and international biosafety guidelines. Which of the following aspects of the BRMS establishment would be the most critical for the auditor to verify as foundational to the system\'s effectiveness and compliance?

Accepted Answer

The documented process for identifying and analyzing internal and external issues relevant to the laboratory's biorisk management, including applicable legal and regulatory requirements, and the identification of interested parties and their needs.

Question 14

During an internal audit of a high-containment research laboratory operating under ISO 35001:2019, an auditor is reviewing the effectiveness of engineering controls. The laboratory utilizes Class II Type B2 biosafety cabinets for handling BSL-3 agents. The auditor finds that while the cabinets are regularly certified according to national standards, the certification reports are stored in a separate archive and are not explicitly referenced in the standard operating procedures (SOPs) for handling specific pathogens or in the laboratory\'s risk assessments for those activities. Which of the following findings would represent the most significant deficiency in the laboratory\'s biorisk management system concerning the use of these engineering controls?

Accepted Answer

The certification reports are not actively integrated into the laboratory's risk assessments or operational procedures, meaning the performance data of the biosafety cabinets may not be influencing day-to-day safety practices or the evaluation of residual risks.

Question 15

When conducting an internal audit of a high-containment biosafety laboratory\'s biorisk management system (BRMS) according to ISO 35001:2019, what is the primary focus for an auditor when evaluating the \"Context of the organization\" and \"Interested parties\" clauses?

Accepted Answer

Verification that the laboratory has systematically identified and documented external and internal factors influencing its BRMS, along with the needs and expectations of relevant stakeholders, including regulatory compliance obligations.

Question 16

During an internal audit of a high-containment virology laboratory, an auditor observes that while a comprehensive risk assessment for handling a novel zoonotic virus has been documented, the specific control measures detailed in the standard operating procedures (SOPs) for decontamination of shared equipment appear to be based on general laboratory practices rather than the unique characteristics and transmission routes of the identified pathogen. The auditor also notes a lack of documented evidence demonstrating the validation of these specific decontamination protocols against the target virus. Considering the principles of ISO 35001:2019, which of the following findings would represent the most significant deficiency in the laboratory\'s biorisk management system?

Accepted Answer

The documented risk assessment does not explicitly detail the validation process for the efficacy of specific decontamination agents against the target biological agent.

Question 17

During an internal audit of a research laboratory handling novel viral vectors, an auditor observes that while Standard Operating Procedures (SOPs) for Biosafety Level 3 (BSL-3) containment are documented and readily available, the actual practices observed during sample processing appear to deviate slightly from the detailed steps outlined for aerosol-generating procedures. Specifically, the negative pressure monitoring logs show consistent readings within acceptable parameters, but the sequence of donning and doffing Personal Protective Equipment (PPE) during a specific manipulation phase does not precisely match the sequence detailed in the SOP for minimizing external contamination. Considering the principles of ISO 35001:2019, what is the primary focus of the internal auditor\'s evaluation in this scenario?

Accepted Answer

Verifying that the implemented operational controls, including the sequence of PPE usage during specific procedures, effectively mitigate the identified biorisks as per the documented risk assessment and relevant biosafety guidelines.

Question 18

An internal auditor is reviewing the implementation of ISO 35001:2019 at a research laboratory specializing in the containment and study of novel arboviruses. The laboratory operates under strict national biosafety guidelines and receives funding from multiple international research consortia. During the audit, it becomes apparent that while the laboratory has detailed protocols for handling biological agents, there\'s a less systematic approach to understanding how changes in international biosafety policy, evolving public discourse on zoonotic disease emergence, and the specific risk tolerance of its diverse funding bodies might impact its biorisk management system\'s long-term viability and compliance. What fundamental aspect of ISO 35001:2019 is the laboratory potentially overlooking in its current biorisk management framework?

Accepted Answer

The systematic identification and analysis of external and internal issues relevant to the organization's purpose and strategic direction.

Question 19

During an internal audit of a biosafety level 3 (BSL-3) laboratory, an auditor is reviewing the documentation related to the establishment of the biorisk management system. The auditor finds that while the laboratory has identified potential biological hazards and implemented containment measures, there is limited evidence of a systematic process for understanding the broader organizational context and the specific needs and expectations of all relevant interested parties, including regulatory oversight bodies and community health organizations. According to ISO 35001:2019, which foundational element is most likely underdeveloped, potentially compromising the overall effectiveness of the biorisk management system?

Accepted Answer

Establishing the context of the organization and understanding the needs and expectations of interested parties

Question 20

During an internal audit of a biosafety level 2 (BSL-2) molecular diagnostics laboratory operating under ISO 35001:2019, an auditor reviews the documented biorisk management system. The laboratory recently conducted a risk assessment for a new assay involving a genetically modified organism (GMO) with a potential for aerosol generation. The risk assessment identified a moderate risk of airborne transmission to personnel. The auditor observes that the standard operating procedure (SOP) for sample handling has not been updated to include specific enhanced containment measures or modified ventilation requirements beyond the general BSL-2 guidelines. What is the most significant finding from an internal audit perspective concerning the effectiveness of the biorisk management system?

Accepted Answer

Failure to integrate risk assessment findings into updated operational procedures, indicating a potential gap in risk treatment implementation.

Question 21

An internal audit of a biosafety level 2 (BSL-2) laboratory handling a novel strain of *Bacillus anthracis* reveals that recent peer-reviewed publications have presented new findings on its aerosolization potential under specific environmental conditions not previously considered in the laboratory\'s risk assessment. The laboratory\'s current Standard Operating Procedures (SOPs) for handling this agent do not explicitly address these newly identified aerosolization factors. What is the most appropriate recommendation for the internal auditor to make to ensure continued compliance with ISO 35001:2019 principles?

Accepted Answer

Initiate a formal review of the existing biorisk assessment and associated control measures, incorporating the new scientific findings on aerosolization potential.

Question 22

During an internal audit of a high-containment virology laboratory, an auditor is examining the operational controls for handling a novel avian influenza strain. The laboratory has developed detailed Standard Operating Procedures (SOPs) for sample receipt, processing, and disposal. However, the auditor observes that the specific controls for managing deviations from these SOPs, particularly those related to accidental spills or containment breaches during sample transfer between Biosafety Level 3 (BSL-3) cabinets, are not explicitly detailed within the primary SOPs but are referenced in a separate, less frequently updated, emergency response plan. Considering the intent of ISO 35001:2019, what is the most significant deficiency an internal auditor would likely identify in this scenario regarding operational planning and control?

Accepted Answer

Inadequate integration of emergency response protocols for deviations within the primary operational procedures.

Question 23

When conducting an internal audit of a high-containment biosafety laboratory operating under ISO 35001:2019, what foundational aspect of the biorisk management system (BRMS) requires the most rigorous scrutiny to ensure its effectiveness in managing potential biological hazards?

Accepted Answer

The comprehensiveness of the initial biorisk assessment, encompassing the laboratory's operational context and relevant stakeholder requirements.

Question 24

During an internal audit of a biosafety level 2 (BSL-2) laboratory operating under ISO 35001:2019, an auditor observes that while the laboratory has documented procedures for decontamination of waste, the actual practice observed during waste disposal involves a shorter contact time for the disinfectant than specified in the procedure. The auditor also notes that the personnel involved in waste handling appear to be rushing the process. Considering the principles of biorisk management and the auditor\'s role in verifying the effectiveness of implemented controls, what is the most appropriate finding for the auditor to document regarding this observation?

Accepted Answer

The implemented waste decontamination control is not demonstrably effective in meeting the specified risk mitigation objectives due to deviations from documented procedures.

Question 25

During an internal audit of a biosafety level 3 (BSL-3) laboratory, an auditor is reviewing the implementation of the biorisk management system (BRMS) according to ISO 35001:2019. The auditor finds that while the laboratory has a robust set of standard operating procedures (SOPs) for handling specific pathogens and a comprehensive emergency response plan, there is no documented evidence of a systematic process for identifying and evaluating how evolving national biosafety regulations and the expectations of the local public health authority regarding pathogen containment are integrated into the laboratory\'s overall biorisk management strategy. Furthermore, top management\'s engagement in reviewing and adapting the BRMS based on these external factors appears to be ad-hoc rather than a structured part of their oversight responsibilities. Which aspect of the ISO 35001:2019 standard is most likely not being adequately addressed, potentially leading to a significant finding?

Accepted Answer

The systematic identification and consideration of external and internal issues, including regulatory requirements and stakeholder expectations, and the demonstration of top management commitment to integrating these into the BRMS.

Question 26

During an internal audit of a biosafety level 3 (BSL-3) laboratory, an auditor is reviewing the implementation of ISO 35001:2019 requirements concerning personnel awareness. The laboratory has conducted several training sessions on general biosafety principles and the laboratory\'s biorisk management policy. However, when interviewing a bench technologist responsible for preparing samples of a novel zoonotic virus, the technologist expresses uncertainty about the specific biosafety level containment requirements for this particular agent beyond the general BSL-3 guidelines and the precise reporting procedure for a minor spill that occurred last week. What is the most critical deficiency the auditor should identify in relation to ISO 35001:2019 clause 7.1.3, \"Awareness\"?

Accepted Answer

Lack of specific awareness regarding the containment requirements for particular biological agents and the detailed procedures for incident reporting.

Question 27

During an internal audit of a biosafety level 3 (BSL-3) laboratory, an auditor is reviewing the documentation for the establishment of the biorisk management system (BRMS). The auditor notes that while the laboratory has conducted a thorough risk assessment for its primary research activities involving highly pathogenic avian influenza, it has not explicitly documented how external regulatory changes concerning the transport of infectious agents or the specific requirements of the national biosafety oversight committee have been integrated into the BRMS\'s scope and objectives. Which aspect of ISO 35001:2019 is most likely being inadequately addressed in this scenario?

Accepted Answer

The systematic identification and consideration of external and internal issues relevant to the BRMS and the needs and expectations of interested parties.

Question 28

During an internal audit of a high-containment laboratory working with a newly identified viral agent, the auditor observes that while the laboratory has developed preliminary handling procedures for the agent, there is no documented evidence of a comprehensive risk assessment that considers the full lifecycle of the agent within the facility, nor is there clear engagement with external regulatory bodies regarding the specific containment requirements for this novel pathogen. Which aspect of ISO 35001:2019 is most critically underserviced in this scenario, requiring immediate attention from the laboratory management?

Accepted Answer

The systematic identification and evaluation of biorisks across all operational stages and the proactive engagement with relevant regulatory authorities to ensure compliance and best practice.

Question 29

During an internal audit of a biosafety laboratory handling moderate-risk pathogens, an auditor is reviewing the status of a Class II, Type A2 biosafety cabinet. The auditor observes that the cabinet is powered on, a researcher is actively working within it, and a certification sticker from the previous year is affixed to the front panel. Which of the following findings would represent the most robust and actionable audit conclusion regarding the cabinet\'s biorisk control effectiveness?

Accepted Answer

The biosafety cabinet's performance characteristics, as detailed in its most recent certification report, are verified to meet the specified operational parameters for the biological agents being handled and the laboratory's risk assessment.

Question 30

During an internal audit of a biosafety level 3 (BSL-3) laboratory, an auditor is reviewing the process for handling patient-derived samples containing suspected novel respiratory pathogens. The laboratory has documented procedures for receipt, processing, and disposal. However, the auditor observes that the primary containment device (biosafety cabinet) used for sample manipulation is not consistently logged for its operational status (e.g., airflow checks, decontamination cycles) by the technicians performing the work. The laboratory\'s biorisk management system, based on ISO 35001:2019, requires documented evidence of control for all critical operational processes. Which of the following findings would represent the most significant non-conformity regarding the laboratory\'s adherence to ISO 35001:2019 principles for this scenario?

Accepted Answer

Failure to maintain comprehensive, real-time operational logs for critical containment equipment, thereby undermining the auditable evidence of process control.

ISO 35001:2019 - Biorisk Management for Laboratories Internal Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 35001:2019 - Biorisk Management for Laboratories Internal Auditor Certification